The Vanguard Group, Inc. > VANGUARD WORLD FUND
VANGUARD HEALTH CARE INDEX FUND
$19.74B
Avg Monthly Net Assets
$20.45B
Total Assets
$65.40M
Total Liabilities
$20.39B
Net Assets
VANGUARD HEALTH CARE INDEX FUND is an Exchange-Traded Fund in VANGUARD WORLD FUND
from The Vanguard Group, Inc.,
based in Pennsylvania,
United States of America.
The fund has two share classes
and monthly net assets of $19.74B.
On July 26th, 2024 it reported 414 holdings, the largest
being Eli Lilly & Co (11.0%), UnitedHealth Group Inc (7.6%) and Johnson & Johnson (5.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Admiral Shares | C000012222 | VHCIX | ||
| ETF Shares | C000012223 | ARCX | VHT |
Holdings
From latest NPORT-P, filed July 26th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS I-A (10X Genomics Inc) | Long | Equity-common | US | $7M | 301K | 0.03 |
| 23ANDME HOLDIN-A (23andMe Holding Co) | Long | Equity-common | US | $507K | 930K | 0.00 |
| 2SEVENTY BIO (2seventy bio Inc) | Long | Equity-common | US | $665K | 157K | 0.00 |
| 89BIO INC | Long | Equity-common | US | $2M | 253K | 0.01 |
| ABBOTT LABS (Abbott Laboratories) | Long | Equity-common | US | $601M | 6M | 2.95 |
| ABBVIE INC | Long | Equity-common | US | $965M | 6M | 4.73 |
| ACADIA HEALTHCAR (Acadia Healthcare Co Inc) | Long | Equity-common | US | $22M | 313K | 0.11 |
| ACADIA PHARMACEU (ACADIA Pharmaceuticals Inc) | Long | Equity-common | US | $5M | 362K | 0.03 |
| ACCOLADE INC | Long | Equity-common | US | $2M | 237K | 0.01 |
| ACELYRIN INC | Long | Equity-common | US | $271K | 66K | 0.00 |
| ACLARIS THERAPEU (Aclaris Therapeutics Inc) | Long | Equity-common | US | $175K | 170K | 0.00 |
| ADAPTHEALTH CORP | Long | Equity-common | US | $2M | 255K | 0.01 |
| ADAPTIVE BIOTECH (Adaptive Biotechnologies Corp) | Long | Equity-common | US | $1M | 345K | 0.01 |
| ADDUS HOMECARE (Addus HomeCare Corp) | Long | Equity-common | US | $6M | 55K | 0.03 |
| ADMA BIOLOGICS INC | Long | Equity-common | US | $7M | 726K | 0.03 |
| ADVAXIS INC-CW24 (Ayala Pharmaceuticals Inc) | Long | Equity-common | US | $0.08 | 8K | 0.00 |
| AEROVATE THERAPE (Aerovate Therapeutics Inc) | Long | Equity-common | US | $491K | 28K | 0.00 |
| AGENUS INC | Long | Equity-common | US | $816K | 52K | 0.00 |
| AGILENT TECH INC (Agilent Technologies Inc) | Long | Equity-common | US | $129M | 993K | 0.64 |
| AGILON HEALTH IN (agilon health Inc) | Long | Equity-common | US | $7M | 1M | 0.03 |
| AGIOS PHARMACEUT (Agios Pharmaceuticals Inc) | Long | Equity-common | US | $7M | 189K | 0.03 |
| AKERO THERAPEUTI (Akero Therapeutics Inc) | Long | Equity-common | US | $3M | 181K | 0.02 |
| AKOYA BIOSCIENCE (Akoya Biosciences Inc) | Long | Equity-common | US | $179K | 83K | 0.00 |
| ALDEYRA THERAPEU (Aldeyra Therapeutics Inc) | Long | Equity-common | US | $612K | 159K | 0.00 |
| ALECTOR INC | Long | Equity-common | US | $1M | 224K | 0.01 |
| ALIGN TECHNOLOGY (Align Technology Inc) | Long | Equity-common | US | $63M | 247K | 0.31 |
| ALIGNMENT HEALTH (Alignment Healthcare Inc) | Long | Equity-common | US | $3M | 349K | 0.01 |
| ALKERMES PLC | Long | Equity-common | US | $13M | 536K | 0.06 |
| ALLOGENE THERAPE (Allogene Therapeutics Inc) | Long | Equity-common | US | $1M | 496K | 0.01 |
| ALNYLAM PHARMACE (Alnylam Pharmaceuticals Inc) | Long | Equity-common | US | $63M | 425K | 0.31 |
| ALPHATEC HOLDING (Alphatec Holdings Inc) | Long | Equity-common | US | $3M | 324K | 0.02 |
| ALTIMMUNE INC | Long | Equity-common | US | $1M | 182K | 0.01 |
| ALX ONCOLOGY HOL (ALX Oncology Holdings Inc) | Long | Equity-common | US | $809K | 76K | 0.00 |
| AMEDISYS INC | Long | Equity-common | US | $10M | 110K | 0.05 |
| AMERICAN WELL -A (American Well Corp) | Long | Equity-common | US | $345K | 809K | 0.00 |
| AMGEN INC | Long | Equity-common | US | $555M | 2M | 2.72 |
| AMICUS THERAPEUT (Amicus Therapeutics Inc) | Long | Equity-common | US | $7M | 746K | 0.04 |
| AMN HEALTHCARE (AMN Healthcare Services Inc) | Long | Equity-common | US | $7M | 128K | 0.04 |
| AMNEAL PHARM INC (Amneal Pharmaceuticals Inc) | Long | Equity-common | US | $3M | 416K | 0.01 |
| AMPHASTAR PHARMA (Amphastar Pharmaceuticals Inc) | Long | Equity-common | US | $6M | 130K | 0.03 |
| AMYLYX PHARMACEU (Amylyx Pharmaceuticals Inc) | Long | Equity-common | US | $256K | 149K | 0.00 |
| ANAPTYSBIO INC | Long | Equity-common | US | $868K | 36K | 0.00 |
| ANAVEX LIFE SCIE (Anavex Life Sciences Corp) | Long | Equity-common | US | $1M | 277K | 0.01 |
| ANGIODYNAMICS IN (AngioDynamics Inc) | Long | Equity-common | US | $851K | 135K | 0.00 |
| ANI PHARMACEUTIC (ANI Pharmaceuticals Inc) | Long | Equity-common | US | $4M | 55K | 0.02 |
| APELLIS PHARMACE (Apellis Pharmaceuticals Inc) | Long | Equity-common | US | $9M | 241K | 0.05 |
| ARCELLX INC | Long | Equity-common | US | $5M | 97K | 0.02 |
| ARCTURUS THERAPE (Arcturus Therapeutics Holdings Inc) | Long | Equity-common | US | $3M | 81K | 0.02 |
| ARCUS BIOSCIENCE (Arcus Biosciences Inc) | Long | Equity-common | US | $3M | 166K | 0.01 |
| ARDELYX INC | Long | Equity-common | US | $5M | 787K | 0.03 |
| ARROWHEAD PHARMA (Arrowhead Pharmaceuticals Inc) | Long | Equity-common | US | $10M | 418K | 0.05 |
| ARTIVION INC | Long | Equity-common | US | $3M | 125K | 0.01 |
| ARVINAS INC | Long | Equity-common | US | $6M | 196K | 0.03 |
| ASTRANA HEALTH I (Astrana Health Inc) | Long | Equity-common | US | $7M | 158K | 0.03 |
| ATAI LIFE SCIENC (ATAI Life Sciences NV) | Long | Equity-common | US | $647K | 412K | 0.00 |
| ATARA BIOTHERAPE (Atara Biotherapeutics Inc) | Long | Equity-common | US | $154K | 275K | 0.00 |
| ATEA PHARMACEUTI (Atea Pharmaceuticals Inc) | Long | Equity-common | US | $781K | 213K | 0.00 |
| ATRICURE INC | Long | Equity-common | US | $4M | 160K | 0.02 |
| ATRION CORP | Long | Equity-common | US | $2M | 5K | 0.01 |
| AURINIA PHARMACE (Aurinia Pharmaceuticals Inc) | Long | Equity-common | US | $3M | 462K | 0.01 |
| AVANOS MEDICAL I (Avanos Medical Inc) | Long | Equity-common | US | $3M | 156K | 0.02 |
| AVANTOR INC | Long | Equity-common | US | $51M | 2M | 0.25 |
| AVEANNA HEALTHCA (Aveanna Healthcare Holdings Inc) | Long | Equity-common | US | $505K | 193K | 0.00 |
| AVID BIOSERVICES (Avid Bioservices Inc) | Long | Equity-common | US | $2M | 214K | 0.01 |
| AVIDITY BIOSCIEN (Avidity Biosciences Inc) | Long | Equity-common | US | $6M | 242K | 0.03 |
| AXONICS INC | Long | Equity-common | US | $12M | 172K | 0.06 |
| AXSOME THERAPEUT (Axsome Therapeutics Inc) | Long | Equity-common | US | $8M | 104K | 0.04 |
| AZENTA INC | Long | Equity-common | US | $9M | 170K | 0.04 |
| BAXTER INTL INC (Baxter International Inc) | Long | Equity-common | US | $59M | 2M | 0.29 |
| BEAM THERAPEUTIC (Beam Therapeutics Inc) | Long | Equity-common | US | $6M | 235K | 0.03 |
| BECTON DICKINSON (Becton Dickinson & Co) | Long | Equity-common | US | $228M | 981K | 1.12 |
| BIO-RAD LABS-A (Bio-Rad Laboratories Inc) | Long | Equity-common | US | $21M | 73K | 0.10 |
| BIO-TECHNE CORP | Long | Equity-common | US | $41M | 536K | 0.20 |
| BIOCRYST PHARM (BioCryst Pharmaceuticals Inc) | Long | Equity-common | US | $4M | 626K | 0.02 |
| BIOGEN INC | Long | Equity-common | US | $110M | 491K | 0.54 |
| BIOHAVEN LTD | Long | Equity-common | US | $9M | 245K | 0.04 |
| BIOLIFE SOLUTION (BioLife Solutions Inc) | Long | Equity-common | US | $3M | 123K | 0.01 |
| BIOMARIN PHARMAC (BioMarin Pharmaceutical Inc) | Long | Equity-common | US | $48M | 638K | 0.23 |
| BIOMEA FUSION IN (Biomea Fusion Inc) | Long | Equity-common | US | $819K | 78K | 0.00 |
| BIONANO GENOMICS (Bionano Genomics Inc) | Long | Equity-common | US | $114K | 118K | 0.00 |
| BLUEPRINT MEDICI (Blueprint Medicines Corp) | Long | Equity-common | US | $21M | 196K | 0.10 |
| BOSTON SCIENTIFC (Boston Scientific Corp) | Long | Equity-common | US | $375M | 5M | 1.84 |
| BRIDGEBIO PHARMA (Bridgebio Pharma Inc) | Long | Equity-common | US | $10M | 354K | 0.05 |
| BRISTOL-MYER SQB (Bristol-Myers Squibb Co) | Long | Equity-common | US | $283M | 7M | 1.39 |
| BROOKDALE SR (Brookdale Senior Living Inc) | Long | Equity-common | US | $4M | 605K | 0.02 |
| BRUKER CORP | Long | Equity-common | US | $20M | 305K | 0.10 |
| BUTTERFLY NETWOR (Butterfly Network Inc) | Long | Equity-common | US | $513K | 516K | 0.00 |
| CABALETTA BIO IN (Cabaletta Bio Inc) | Long | Equity-common | US | $1M | 102K | 0.01 |
| CARA THERAPEUTIC (Cara Therapeutics Inc) | Long | Equity-common | US | $108K | 166K | 0.00 |
| CARDINAL HEALTH (Cardinal Health Inc) | Long | Equity-common | US | $83M | 835K | 0.41 |
| CAREDX INC | Long | Equity-common | US | $2M | 183K | 0.01 |
| CAREMAX INC | Long | Equity-common | US | $20K | 7K | 0.00 |
| CASSAVA SCIENCES (Cassava Sciences Inc) | Long | Equity-common | US | $3M | 137K | 0.01 |
| CASTLE BIOSCIENC (Castle Biosciences Inc) | Long | Equity-common | US | $2M | 86K | 0.01 |
| CATALENT INC | Long | Equity-common | US | $33M | 612K | 0.16 |
| CATALYST PHARMAC (Catalyst Pharmaceuticals Inc) | Long | Equity-common | US | $6M | 359K | 0.03 |
| CELLDEX THERAPEU (Celldex Therapeutics Inc) | Long | Equity-common | US | $7M | 197K | 0.03 |
| CENCORA INC | Long | Equity-common | US | $131M | 578K | 0.64 |
| CENTENE CORP | Long | Equity-common | US | $130M | 2M | 0.64 |
| CENTURY THERAPEU (Century Therapeutics Inc) | Long | Equity-common | US | $209K | 70K | 0.00 |
| CEREVEL THERAPEU (Cerevel Therapeutics Holdings Inc) | Long | Equity-common | US | $10M | 246K | 0.05 |
| CERTARA INC | Long | Equity-common | US | $6M | 378K | 0.03 |
| CERUS CORP | Long | Equity-common | US | $1M | 609K | 0.01 |
| CHARLES RIVER LA (Charles River Laboratories International Inc) | Long | Equity-common | US | $36M | 174K | 0.18 |
| CHEMED CORP | Long | Equity-common | US | $27M | 48K | 0.13 |
| CHINOOK THERAPEUTICS INC - CVR (AUG 2023) | Long | Equity-common | US | $305.76 | 784 | 0.00 |
| CLOVER HEALTH IN (Clover Health Investments Corp) | Long | Equity-common | US | $1M | 1M | 0.01 |
| CODEXIS INC | Long | Equity-common | US | $801K | 237K | 0.00 |
| COGENT BIOSCIENC (Cogent Biosciences Inc) | Long | Equity-common | US | $2M | 211K | 0.01 |
| COHERUS BIOSCIEN (Coherus Biosciences Inc) | Long | Equity-common | US | $614K | 337K | 0.00 |
| COLLEGIUM PHARMA (Collegium Pharmaceutical Inc) | Long | Equity-common | US | $4M | 111K | 0.02 |
| COMMUNITY HEALTH (Community Health Systems Inc) | Long | Equity-common | US | $2M | 441K | 0.01 |
| CONMED CORP | Long | Equity-common | US | $8M | 104K | 0.04 |
| COOPER COS INC (Cooper Cos Inc/The) | Long | Equity-common | US | $63M | 671K | 0.31 |
| CORCEPT THERA (Corcept Therapeutics Inc) | Long | Equity-common | US | $9M | 297K | 0.04 |
| CORVEL CORP | Long | Equity-common | US | $8M | 32K | 0.04 |
| CRINETICS PHARMA (Crinetics Pharmaceuticals Inc) | Long | Equity-common | US | $10M | 217K | 0.05 |
| CRISPR THERAPEUT (CRISPR Therapeutics AG) | Long | Equity-common | US | $14M | 256K | 0.07 |
| CROSS COUNTRY HE (Cross Country Healthcare Inc) | Long | Equity-common | US | $2M | 112K | 0.01 |
| CRYOPORT (CryoPort Inc) | Long | Equity-common | US | $2M | 165K | 0.01 |
| CULLINAN THERAPE (Cullinan Therapeutics Inc) | Long | Equity-common | US | $3M | 126K | 0.01 |
| CUTERA INC | Long | Equity-common | US | $101K | 47K | 0.00 |
| CVS HEALTH CORP | Long | Equity-common | US | $260M | 4M | 1.27 |
| CYTEK BIOSCIENCE (Cytek Biosciences Inc) | Long | Equity-common | US | $2M | 368K | 0.01 |
| CYTOKINETICS INC | Long | Equity-common | US | $15M | 299K | 0.07 |
| DANAHER CORP | Long | Equity-common | US | $611M | 2M | 3.00 |
| DAVITA INC | Long | Equity-common | US | $27M | 186K | 0.13 |
| DAY ONE BIOPHARM (Day One Biopharmaceuticals Inc) | Long | Equity-common | US | $2M | 162K | 0.01 |
| DECIPHERA PHARMA (Deciphera Pharmaceuticals Inc) | Long | Equity-common | US | $3M | 123K | 0.02 |
| DEFINITIVE HEALT (Definitive Healthcare Corp) | Long | Equity-common | US | $946K | 178K | 0.00 |
| DENALI THERAPEUT (Denali Therapeutics Inc) | Long | Equity-common | US | $7M | 375K | 0.03 |
| DENTSPLY SIRONA (DENTSPLY SIRONA Inc) | Long | Equity-common | US | $20M | 718K | 0.10 |
| DEXCOM (Dexcom Inc) | Long | Equity-common | US | $155M | 1M | 0.76 |
| DISC MEDICINE IN (Disc Medicine Inc) | Long | Equity-common | US | $1M | 41K | 0.01 |
| DOCGO INC | Long | Equity-common | US | $874K | 298K | 0.00 |
| DOXIMITY INC-A | Long | Equity-common | US | $10M | 371K | 0.05 |
| DYNAVAX TECHNOLO (Dynavax Technologies Corp) | Long | Equity-common | US | $5M | 416K | 0.02 |
| EAGLE PHARMACEUT (Eagle Pharmaceuticals Inc/DE) | Long | Equity-common | US | $140K | 40K | 0.00 |
| EDITAS MEDICINE (Editas Medicine Inc) | Long | Equity-common | US | $1M | 248K | 0.01 |
| EDWARDS LIFE (Edwards Lifesciences Corp) | Long | Equity-common | US | $179M | 2M | 0.88 |
| ELANCO ANIMAL HE (Elanco Animal Health Inc) | Long | Equity-common | US | $30M | 2M | 0.14 |
| ELEVANCE HEALTH (Elevance Health Inc) | Long | Equity-common | US | $429M | 796K | 2.10 |
| ELI LILLY & CO | Long | Equity-common | US | $2B | 3M | 11.00 |
| EMBECTA CORP | Long | Equity-common | US | $2M | 194K | 0.01 |
| EMERGENT BIOSOLU (Emergent BioSolutions Inc) | Long | Equity-common | US | $977K | 171K | 0.00 |
| ENANTA PHARMACEU (Enanta Pharmaceuticals Inc) | Long | Equity-common | US | $840K | 67K | 0.00 |
| ENCOMPASS HEALTH (Encompass Health Corp) | Long | Equity-common | US | $29M | 339K | 0.14 |
| ENHABIT INC | Long | Equity-common | US | $1M | 144K | 0.01 |
| ENLIVEN THERAPEU (Enliven Therapeutics Inc) | Long | Equity-common | US | $1M | 63K | 0.01 |
| ENOVIS CORP | Long | Equity-common | US | $8M | 166K | 0.04 |
| ENSIGN GROUP INC (Ensign Group Inc/The) | Long | Equity-common | US | $23M | 191K | 0.11 |
| ENTRADA THERAPEU (Entrada Therapeutics Inc) | Long | Equity-common | US | $595K | 38K | 0.00 |
| ENVISTA HOLDINGS (Envista Holdings Corp) | Long | Equity-common | US | $11M | 582K | 0.06 |
| ERASCA INC | Long | Equity-common | US | $2M | 662K | 0.01 |
| ESTABLISHMENT LA (Establishment Labs Holdings Inc) | Long | Equity-common | US | $3M | 65K | 0.02 |
| EVOLENT HEALTH-A (Evolent Health Inc) | Long | Equity-common | US | $7M | 351K | 0.04 |
| EVOLUS INC | Long | Equity-common | US | $2M | 165K | 0.01 |
| EXACT SCIENCES (Exact Sciences Corp) | Long | Equity-common | US | $28M | 612K | 0.14 |
| EXELIXIS INC | Long | Equity-common | US | $21M | 947K | 0.10 |
| FATE THERAPEUTIC (Fate Therapeutics Inc) | Long | Equity-common | US | $996K | 271K | 0.00 |
| FIBROGEN INC | Long | Equity-common | US | $390K | 325K | 0.00 |
| FOGHORN THERAPEU (Foghorn Therapeutics Inc) | Long | Equity-common | US | $657K | 113K | 0.00 |
| FORTREA HOLDINGS (Fortrea Holdings Inc) | Long | Equity-common | US | $7M | 286K | 0.04 |
| FULGENT GENETICS (Fulgent Genetics Inc) | Long | Equity-common | US | $1M | 66K | 0.01 |
| GE HEALTHCARE TE (GE HealthCare Technologies Inc) | Long | Equity-common | US | $108M | 1M | 0.53 |
| GERON CORP | Long | Equity-common | US | $5M | 1M | 0.02 |
| GERON CORP-WT25 | Long | Equity-common | US | $162K | 152K | 0.00 |
| GILEAD SCIENCES (Gilead Sciences Inc) | Long | Equity-common | US | $271M | 4M | 1.33 |
| GLAUKOS CORP | Long | Equity-common | US | $18M | 157K | 0.09 |
| GLOBUS MEDICAL I (Globus Medical Inc) | Long | Equity-common | US | $20M | 291K | 0.10 |
| GOODRX HOLDIN-A (GoodRx Holdings Inc) | Long | Equity-common | US | $2M | 266K | 0.01 |
| GOSSAMER BIO INC | Long | Equity-common | US | $384K | 651K | 0.00 |
| GUARDANT HEALTH (Guardant Health Inc) | Long | Equity-common | US | $11M | 391K | 0.05 |
| HAEMONETICS CORP | Long | Equity-common | US | $14M | 172K | 0.07 |
| HALOZYME THERAPE (Halozyme Therapeutics Inc) | Long | Equity-common | US | $20M | 447K | 0.10 |
| HARMONY BIOSCIE (Harmony Biosciences Holdings Inc) | Long | Equity-common | US | $3M | 109K | 0.02 |
| HARROW INC | Long | Equity-common | US | $2M | 101K | 0.01 |
| HCA HEALTHCARE I (HCA Healthcare Inc) | Long | Equity-common | US | $231M | 680K | 1.13 |
| HEALTH CATALYST (Health Catalyst Inc) | Long | Equity-common | US | $1M | 192K | 0.01 |
| HEALTHEQUITY INC | Long | Equity-common | US | $24M | 290K | 0.12 |
| HEALTHSTREAM INC | Long | Equity-common | US | $2M | 81K | 0.01 |
| HENRY SCHEIN INC | Long | Equity-common | US | $31M | 440K | 0.15 |
| HERON THERAPEUTI (Heron Therapeutics Inc) | Long | Equity-common | US | $1M | 358K | 0.01 |
| HILLEVAX INC | Long | Equity-common | US | $796K | 66K | 0.00 |
| HIMS & HERS HEAL (Hims & Hers Health Inc) | Long | Equity-common | US | $9M | 484K | 0.05 |
| HOLOGIC INC | Long | Equity-common | US | $60M | 813K | 0.29 |
| HUMACYTE INC | Long | Equity-common | US | $2M | 229K | 0.01 |
| HUMANA INC | Long | Equity-common | US | $149M | 417K | 0.73 |
| ICU MEDICAL (ICU Medical Inc) | Long | Equity-common | US | $7M | 69K | 0.04 |
| IDEAYA BIOSCIENC (Ideaya Biosciences Inc) | Long | Equity-common | US | $7M | 191K | 0.03 |
| IDEXX LABS (IDEXX Laboratories Inc) | Long | Equity-common | US | $140M | 281K | 0.69 |
| IGM BIOSCIENCES (IGM Biosciences Inc) | Long | Equity-common | US | $326K | 39K | 0.00 |
| ILLUMINA INC | Long | Equity-common | US | $56M | 538K | 0.28 |
| IMMUNITYBIO INC | Long | Equity-common | US | $3M | 452K | 0.01 |
| IMMUNOVANT INC | Long | Equity-common | US | $4M | 171K | 0.02 |
| INARI MEDICAL IN (Inari Medical Inc) | Long | Equity-common | US | $9M | 176K | 0.04 |
| INCYTE CORP | Long | Equity-common | US | $37M | 645K | 0.18 |
| INNOVIVA INC | Long | Equity-common | US | $3M | 194K | 0.02 |
| INOGEN INC | Long | Equity-common | US | $654K | 79K | 0.00 |
| INOVIO PHARMACEU (Inovio Pharmaceuticals Inc) | Long | Equity-common | US | $776K | 77K | 0.00 |
| INSMED INC | Long | Equity-common | US | $25M | 460K | 0.12 |
| INSPIRE MEDICAL (Inspire Medical Systems Inc) | Long | Equity-common | US | $16M | 100K | 0.08 |
| INSULET CORP | Long | Equity-common | US | $42M | 237K | 0.21 |
| INTEGER HOLDINGS (Integer Holdings Corp) | Long | Equity-common | US | $14M | 113K | 0.07 |
| INTEGRA LIFESCIE (Integra LifeSciences Holdings Corp) | Long | Equity-common | US | $7M | 226K | 0.03 |
| INTELLIA THERAPE (Intellia Therapeutics Inc) | Long | Equity-common | US | $6M | 288K | 0.03 |
| INTRA-CELLULAR T (Intra-Cellular Therapies Inc) | Long | Equity-common | US | $20M | 293K | 0.10 |
| INTUITIVE SURGIC (Intuitive Surgical Inc) | Long | Equity-common | US | $480M | 1M | 2.35 |
| IONIS PHARMACEUT (Ionis Pharmaceuticals Inc) | Long | Equity-common | US | $16M | 438K | 0.08 |
| IOVANCE BIOTHERA (Iovance Biotherapeutics Inc) | Long | Equity-common | US | $6M | 651K | 0.03 |
| IQVIA HOLDINGS I (IQVIA Holdings Inc) | Long | Equity-common | US | $135M | 618K | 0.66 |
| IRHYTHM TECHNOLO (iRhythm Technologies Inc) | Long | Equity-common | US | $9M | 104K | 0.05 |
| IRONWOOD PHARMAC (Ironwood Pharmaceuticals Inc) | Long | Equity-common | US | $3M | 476K | 0.01 |
| ITEOS THERAPEUTI (iTeos Therapeutics Inc) | Long | Equity-common | US | $1M | 79K | 0.01 |
| JANUX THERAPEUTI (Janux Therapeutics Inc) | Long | Equity-common | US | $3M | 55K | 0.01 |
| JAZZ PHARMACEUTI (Jazz Pharmaceuticals PLC) | Long | Equity-common | US | $21M | 203K | 0.10 |
| JOHNSON&JOHNSON (Johnson & Johnson) | Long | Equity-common | US | $1B | 8M | 5.80 |
| KEROS THERAPEUTI (Keros Therapeutics Inc) | Long | Equity-common | US | $4M | 86K | 0.02 |
| KINIKSA PHARMA-A (Kiniksa Pharmaceuticals Ltd) | Long | Equity-common | US | $2M | 96K | 0.01 |
| KRYSTAL BIOTECH (Krystal Biotech Inc) | Long | Equity-common | US | $10M | 62K | 0.05 |
| KURA ONCOLOGY IN (Kura Oncology Inc) | Long | Equity-common | US | $4M | 175K | 0.02 |
| KYMERA THERAPEUT (Kymera Therapeutics Inc) | Long | Equity-common | US | $4M | 137K | 0.02 |
| LABCORP HOLDINGS (Labcorp Holdings Inc) | Long | Equity-common | US | $56M | 288K | 0.27 |
| LANTHEUS HOLDING (Lantheus Holdings Inc) | Long | Equity-common | US | $19M | 232K | 0.09 |
| LEMAITRE VASCULA (LeMaitre Vascular Inc) | Long | Equity-common | US | $5M | 68K | 0.03 |
| LIGAND PHARM (Ligand Pharmaceuticals Inc) | Long | Equity-common | US | $5M | 56K | 0.02 |
| LIQUIDIA CORP | Long | Equity-common | US | $2M | 153K | 0.01 |
| LIVANOVA PLC | Long | Equity-common | US | $11M | 182K | 0.05 |
| LYELL IMMUNOPHAR (Lyell Immunopharma Inc) | Long | Equity-common | US | $1M | 423K | 0.01 |
| MACROGENICS INC | Long | Equity-common | US | $645K | 158K | 0.00 |
| MADRIGAL PHARMAC (Madrigal Pharmaceuticals Inc) | Long | Equity-common | US | $9M | 40K | 0.05 |
| MANNKIND CORP | Long | Equity-common | US | $4M | 911K | 0.02 |
| MARAVAI LIFESC-A (Maravai LifeSciences Holdings Inc) | Long | Equity-common | US | $3M | 380K | 0.02 |
| MASIMO CORP | Long | Equity-common | US | $19M | 152K | 0.09 |
| MAXCYTE INC | Long | Equity-common | US | $1M | 297K | 0.01 |
| MCKESSON CORP | Long | Equity-common | US | $257M | 451K | 1.26 |
| MEDPACE HOLDINGS (Medpace Holdings Inc) | Long | Equity-common | US | $32M | 83K | 0.16 |
| MEDTRONIC PLC | Long | Equity-common | US | $367M | 5M | 1.80 |
| MEIRAGTX HOLDING (MeiraGTx Holdings plc) | Long | Equity-common | US | $647K | 132K | 0.00 |
| MERCK & CO (Merck & Co Inc) | Long | Equity-common | US | $1B | 9M | 5.29 |
| MERIT MEDICAL (Merit Medical Systems Inc) | Long | Equity-common | US | $16M | 196K | 0.08 |
| MERUS NV | Long | Equity-common | US | $7M | 127K | 0.03 |
| MESA LABS (Mesa Laboratories Inc) | Long | Equity-common | US | $2M | 18K | 0.01 |
| METTLER-TOLEDO (Mettler-Toledo International Inc) | Long | Equity-common | US | $103M | 73K | 0.51 |
| MIMEDX GROUP INC | Long | Equity-common | US | $3M | 398K | 0.01 |
| MIRUM PHARMACEUT (Mirum Pharmaceuticals Inc) | Long | Equity-common | US | $2M | 103K | 0.01 |
| MODERNA INC | Long | Equity-common | US | $157M | 1M | 0.77 |
| MODIVCARE INC | Long | Equity-common | US | $1M | 38K | 0.01 |
| MOLINA HEALTHCAR (Molina Healthcare Inc) | Long | Equity-common | US | $62M | 198K | 0.30 |
| MONTE ROSA THERA (Monte Rosa Therapeutics Inc) | Long | Equity-common | US | $491K | 119K | 0.00 |
| MOONLAKE IMMUNOT (MoonLake Immunotherapeutics) | Long | Equity-common | US | $2M | 61K | 0.01 |
| MORPHIC HOLDING (Morphic Holding Inc) | Long | Equity-common | US | $3M | 101K | 0.02 |
| MULTIPLAN CORP | Long | Equity-common | US | $472K | 878K | 0.00 |
| MURAL ONCOLOGY (Mural Oncology PLC) | Long | Equity-common | US | $170K | 51K | 0.00 |
| MYRIAD GENETICS (Myriad Genetics Inc) | Long | Equity-common | US | $7M | 300K | 0.03 |
| NATERA INC | Long | Equity-common | US | $41M | 387K | 0.20 |
| NATL HEALTHCARE (National HealthCare Corp) | Long | Equity-common | US | $5M | 47K | 0.02 |
| NAUTILUS BIOTECH (Nautilus Biotechnology Inc) | Long | Equity-common | US | $346K | 126K | 0.00 |
| NEKTAR THERAPEUT (Nektar Therapeutics) | Long | Equity-common | US | $774K | 610K | 0.00 |
| NEOGEN CORP | Long | Equity-common | US | $9M | 696K | 0.04 |
| NEOGENOMICS INC | Long | Equity-common | US | $6M | 432K | 0.03 |
| NEUROCRINE BIOSC (Neurocrine Biosciences Inc) | Long | Equity-common | US | $45M | 333K | 0.22 |
| NEVRO CORP | Long | Equity-common | US | $1M | 111K | 0.01 |
| NOVAVAX INC | Long | Equity-common | US | $5M | 363K | 0.03 |
| NOVOCURE LTD | Long | Equity-common | US | $8M | 343K | 0.04 |
| NURIX THERAPEUTI (Nurix Therapeutics Inc) | Long | Equity-common | US | $2M | 131K | 0.01 |
| NUVALENT INC-A | Long | Equity-common | US | $6M | 87K | 0.03 |
| NUVATION BIO INC | Long | Equity-common | US | $1M | 374K | 0.01 |
| OCUGEN INC | Long | Equity-common | US | $2M | 875K | 0.01 |
| OMNIAB INC | Long | Equity-common | US | $1M | 293K | 0.01 |
| OMNIAB INC - 12.5 (OmniAb Operations Inc) | Long | Equity-common | US | $0.22 | 22K | 0.00 |
| OMNIAB INC - 15 (OmniAb Operations Inc) | Long | Equity-common | US | $0.22 | 22K | 0.00 |
| OMNICELL INC | Long | Equity-common | US | $5M | 155K | 0.02 |
| OPKO HEALTH (OPKO Health Inc) | Long | Equity-common | US | $2M | 1M | 0.01 |
| OPTIMIZERX CORP | Long | Equity-common | US | $667K | 55K | 0.00 |
| OPTION CARE HEAL (Option Care Health Inc) | Long | Equity-common | US | $18M | 600K | 0.09 |
| ORASURE TECH (OraSure Technologies Inc) | Long | Equity-common | US | $1M | 249K | 0.01 |
| ORGANOGENESIS HO (Organogenesis Holdings Inc) | Long | Equity-common | US | $551K | 200K | 0.00 |
| ORGANON & CO | Long | Equity-common | US | $18M | 865K | 0.09 |
| ORTHOFIX MEDICAL (Orthofix Medical Inc) | Long | Equity-common | US | $2M | 113K | 0.01 |
| ORTHOPEDIATRICS (OrthoPediatrics Corp) | Long | Equity-common | US | $2M | 55K | 0.01 |
| OUTSET MEDICAL I (Outset Medical Inc) | Long | Equity-common | US | $594K | 159K | 0.00 |
| OWENS & MINOR (Owens & Minor Inc) | Long | Equity-common | US | $4M | 234K | 0.02 |
| PACIFIC BIOSCIEN (Pacific Biosciences of California Inc) | Long | Equity-common | US | $1M | 817K | 0.01 |
| PACIRA BIOSCIENC (Pacira BioSciences Inc) | Long | Equity-common | US | $5M | 157K | 0.02 |
| PARAGON 28 INC | Long | Equity-common | US | $974K | 127K | 0.00 |
| PATTERSON COS (Patterson Cos Inc) | Long | Equity-common | US | $7M | 283K | 0.03 |
| PDL BIOPHARMA IN (PDL BioPharma Inc) | Long | Equity-common | US | $370K | 311K | 0.00 |
| PEDIATRIX MEDICA (Pediatrix Medical Group Inc) | Long | Equity-common | US | $2M | 269K | 0.01 |
| PENNANT GROUP-WI (Pennant Group Inc/The) | Long | Equity-common | US | $2M | 96K | 0.01 |
| PENUMBRA INC | Long | Equity-common | US | $24M | 124K | 0.12 |
| PERRIGO CO PLC | Long | Equity-common | US | $13M | 460K | 0.06 |
| PETIQ INC | Long | Equity-common | US | $2M | 94K | 0.01 |
| PFIZER INC | Long | Equity-common | US | $548M | 19M | 2.69 |
| PHATHOM PHARMACE (Phathom Pharmaceuticals Inc) | Long | Equity-common | US | $909K | 97K | 0.00 |
| PHIBRO ANIMAL-A (Phibro Animal Health Corp) | Long | Equity-common | US | $1M | 68K | 0.01 |
| PHREESIA INC | Long | Equity-common | US | $3M | 179K | 0.02 |
| PLIANT THERAPEUT (Pliant Therapeutics Inc) | Long | Equity-common | US | $2M | 152K | 0.01 |
| PMV PHARMACEUTIC (PMV Pharmaceuticals Inc) | Long | Equity-common | US | $179K | 99K | 0.00 |
| PREMIER INC-CL A | Long | Equity-common | US | $8M | 406K | 0.04 |
| PRESTIGE CONSUME (Prestige Consumer Healthcare Inc) | Long | Equity-common | US | $11M | 168K | 0.05 |
| PREVAIL THERAPEU - CVR (Prevail Therapeutics Inc) | Long | Equity-common | US | $39 | 78 | 0.00 |
| PRIME MEDICINE I (Prime Medicine Inc) | Long | Equity-common | US | $925K | 143K | 0.00 |
| PRIVIA HEALTH GR (Privia Health Group Inc) | Long | Equity-common | US | $6M | 321K | 0.03 |
| PROCEPT BIOROBOT (PROCEPT BioRobotics Corp) | Long | Equity-common | US | $10M | 154K | 0.05 |
| PROGYNY INC | Long | Equity-common | US | $8M | 293K | 0.04 |
| PROTAGONIST THER (Protagonist Therapeutics Inc) | Long | Equity-common | US | $4M | 156K | 0.02 |
| PROTHENA CORP PL (Prothena Corp PLC) | Long | Equity-common | US | $3M | 137K | 0.01 |
| PTC THERAPEUTICS (PTC Therapeutics Inc) | Long | Equity-common | US | $8M | 230K | 0.04 |
| PULMONX CORP | Long | Equity-common | US | $839K | 116K | 0.00 |
| QUANTERIX CORP | Long | Equity-common | US | $2M | 123K | 0.01 |
| QUANTUM-SI INC | Long | Equity-common | US | $522K | 343K | 0.00 |
| QUEST DIAGNOSTIC (Quest Diagnostics Inc) | Long | Equity-common | US | $54M | 381K | 0.27 |
| QUIDELORTHO CORP | Long | Equity-common | US | $8M | 170K | 0.04 |
| R1 RCM INC | Long | Equity-common | US | $7M | 570K | 0.04 |
| RADNET INC | Long | Equity-common | US | $11M | 196K | 0.06 |
| RAPT THERAPEUTIC (RAPT Therapeutics Inc) | Long | Equity-common | US | $305K | 76K | 0.00 |
| Receive AVANTOR INC Pay Overnight Rate | Derivative-equity | $-24K | – | -0.00 | ||
| Receive GLOBUS MEDICAL I Pay Overnight Rate | Derivative-equity | $2M | – | 0.01 | ||
| Receive JOHNSON&JOHNSON Pay Overnight Rate | Derivative-equity | $-600K | – | -0.00 | ||
| Receive SAREPTA THERAPEU Pay Overnight Rate | Derivative-equity | $208K | – | 0.00 | ||
| RECURSION PHAR-A (Recursion Pharmaceuticals Inc) | Long | Equity-common | US | $4M | 530K | 0.02 |
| REGENERON PHARM (Regeneron Pharmaceuticals Inc) | Long | Equity-common | US | $356M | 363K | 1.75 |
| REGENXBIO INC | Long | Equity-common | US | $2M | 140K | 0.01 |
| RELAY THERAPEUTI (Relay Therapeutics Inc) | Long | Equity-common | US | $2M | 282K | 0.01 |
| REPARE THERAPEUT (Repare Therapeutics Inc) | Long | Equity-common | US | $194K | 56K | 0.00 |
| REPLIGEN CORP | Long | Equity-common | US | $27M | 180K | 0.13 |
| REPLIMUNE GROUP (Replimune Group Inc) | Long | Equity-common | US | $632K | 120K | 0.00 |
| RESMED INC | Long | Equity-common | US | $103M | 498K | 0.50 |
| REVANCE THERAPEU (Revance Therapeutics Inc) | Long | Equity-common | US | $950K | 335K | 0.00 |
| REVOLUTION MEDIC (REVOLUTION Medicines Inc) | Long | Equity-common | US | $13M | 344K | 0.06 |
| REVVITY INC | Long | Equity-common | US | $46M | 418K | 0.22 |
| RHYTHM PHARMACEU (Rhythm Pharmaceuticals Inc) | Long | Equity-common | US | $6M | 160K | 0.03 |
| ROCKET PHARMACEU (Rocket Pharmaceuticals Inc) | Long | Equity-common | US | $5M | 214K | 0.02 |
| ROIVANT SCIENCES (Roivant Sciences Ltd) | Long | Equity-common | US | $10M | 954K | 0.05 |
| ROYALTY PHARMA-A (Royalty Pharma PLC) | Long | Equity-common | US | $35M | 1M | 0.17 |
| RXSIGHT INC | Long | Equity-common | US | $5M | 91K | 0.03 |
| SAGE THERAPEUTIC (Sage Therapeutics Inc) | Long | Equity-common | US | $2M | 182K | 0.01 |
| SANA BIOTECHNOLO (Sana Biotechnology Inc) | Long | Equity-common | US | $2M | 333K | 0.01 |
| SANGAMO THERAPEU (Sangamo Therapeutics Inc) | Long | Equity-common | US | $295K | 523K | 0.00 |
| SAREPTA THERAPEU (Sarepta Therapeutics Inc) | Long | Equity-common | US | $29M | 220K | 0.14 |
| SCHRODINGER INC (Schrodinger Inc/United States) | Long | Equity-common | US | $5M | 214K | 0.02 |
| SCILEX HOLDING CO - RESTRICTED LINE (Sorrento Therapeutics Inc) | Long | Equity-common | US | $214K | 220K | 0.00 |
| SEER INC | Long | Equity-common | US | $274K | 152K | 0.00 |
| SELECT MEDICAL (Select Medical Holdings Corp) | Long | Equity-common | US | $13M | 370K | 0.06 |
| SENSEONICS HLDGS (Senseonics Holdings Inc) | Long | Equity-common | US | $578K | 1M | 0.00 |
| SERES THERAPEUTI (Seres Therapeutics Inc) | Long | Equity-common | US | $352K | 352K | 0.00 |
| SHARECARE INC | Long | Equity-common | US | $843K | 1M | 0.00 |
| SHOCKWAVE MEDICA (Shockwave Medical Inc) | Long | Equity-common | US | $9M | 25K | 0.04 |
| SI-BONE INC | Long | Equity-common | US | $2M | 124K | 0.01 |
| SIGA TECH INC (SIGA Technologies Inc) | Long | Equity-common | US | $1M | 144K | 0.01 |
| SILK ROAD MEDICA (Silk Road Medical Inc) | Long | Equity-common | US | $3M | 125K | 0.01 |
| SIMULATIONS PLUS (Simulations Plus Inc) | Long | Equity-common | US | $3M | 54K | 0.01 |
| SOLVENTUM (Solventum Corp) | Long | Equity-common | US | $30M | 497K | 0.14 |
| SOTERA HEALTH CO | Long | Equity-common | US | $4M | 334K | 0.02 |
| SPRINGWORKS THER (SpringWorks Therapeutics Inc) | Long | Equity-common | US | $7M | 159K | 0.03 |
| STAAR SURGICAL (STAAR Surgical Co) | Long | Equity-common | US | $6M | 133K | 0.03 |
| STANDARD BIOTOOL (Standard BioTools Inc) | Long | Equity-common | US | $2M | 737K | 0.01 |
| STERIS PLC | Long | Equity-common | US | $75M | 335K | 0.37 |
| STOKE THERAPEUTI (Stoke Therapeutics Inc) | Long | Equity-common | US | $986K | 67K | 0.00 |
| STRYKER CORP | Long | Equity-common | US | $395M | 1M | 1.94 |
| SUMMIT THERAPEUT (Summit Therapeutics Inc) | Long | Equity-common | US | $4M | 472K | 0.02 |
| SUPERNUS PHARMAC (Supernus Pharmaceuticals Inc) | Long | Equity-common | US | $5M | 186K | 0.02 |
| SURGERY PARTNERS (Surgery Partners Inc) | Long | Equity-common | US | $7M | 236K | 0.03 |
| SURMODICS INC | Long | Equity-common | US | $2M | 48K | 0.01 |
| SYNDAX PHARMACEU (Syndax Pharmaceuticals Inc) | Long | Equity-common | US | $5M | 259K | 0.02 |
| TANDEM DIABETES (Tandem Diabetes Care Inc) | Long | Equity-common | US | $11M | 221K | 0.06 |
| TANGO THERAPEUTI (Tango Therapeutics Inc) | Long | Equity-common | US | $952K | 138K | 0.00 |
| TARSUS PHARMACEU (Tarsus Pharmaceuticals Inc) | Long | Equity-common | US | $2M | 73K | 0.01 |
| TELADOC HEALTH I (Teladoc Health Inc) | Long | Equity-common | US | $6M | 562K | 0.03 |
| TELEFLEX INC | Long | Equity-common | US | $33M | 159K | 0.16 |
| TENET HEALTHCARE (Tenet Healthcare Corp) | Long | Equity-common | US | $42M | 310K | 0.21 |
| TERNS PHARMACEUT (Terns Pharmaceuticals Inc) | Long | Equity-common | US | $631K | 105K | 0.00 |
| TG THERAPEUTICS (TG Therapeutics Inc) | Long | Equity-common | US | $8M | 489K | 0.04 |
| THE CIGNA GROUP (Cigna Group/The) | Long | Equity-common | US | $342M | 991K | 1.68 |
| THERAVANCE B (Theravance Biopharma Inc) | Long | Equity-common | US | $1M | 127K | 0.01 |
| THERMO FISHER (Thermo Fisher Scientific Inc) | Long | Equity-common | US | $744M | 1M | 3.65 |
| TILRAY BRANDS IN (Tilray Brands Inc) | Long | Equity-common | US | $5M | 3M | 0.02 |
| TRANSMEDICS GROU (TransMedics Group Inc) | Long | Equity-common | US | $15M | 111K | 0.07 |
| TRAVERE THERAPEU (Travere Therapeutics Inc) | Long | Equity-common | US | $2M | 254K | 0.01 |
| TREACE MEDICAL C (Treace Medical Concepts Inc) | Long | Equity-common | US | $920K | 156K | 0.00 |
| TWIST BIOSCIENCE (Twist Bioscience Corp) | Long | Equity-common | US | $8M | 196K | 0.04 |
| UFP TECHNOLOGIES (UFP Technologies Inc) | Long | Equity-common | US | $6M | 25K | 0.03 |
| ULTRAGENYX PHARM (Ultragenyx Pharmaceutical Inc) | Long | Equity-common | US | $10M | 251K | 0.05 |
| UNIQURE NV | Long | Equity-common | US | $721K | 146K | 0.00 |
| UNITED THERAPEUT (United Therapeutics Corp) | Long | Equity-common | US | $44M | 159K | 0.21 |
| UNITEDHEALTH GRP (UnitedHealth Group Inc) | Long | Equity-common | US | $2B | 3M | 7.62 |
| UNIVERSAL HLTH-B (Universal Health Services Inc) | Long | Equity-common | US | $39M | 207K | 0.19 |
| US PHYSICAL THER (US Physical Therapy Inc) | Long | Equity-common | US | $5M | 51K | 0.03 |
| VANDA PHARMACEUT (Vanda Pharmaceuticals Inc) | Long | Equity-common | US | $1M | 197K | 0.00 |
| Vanguard Market Liquidity Fund (Vanguard Cmt Funds-Vanguard Market Liquidity Fund) | Long | Short-term investment vehicle | US | $31M | 306K | 0.15 |
| Vanguard Market Liquidity Fund (Vanguard Cmt Funds-Vanguard Market Liquidity Fund) | Long | Short-term investment vehicle | US | $364K | 364K | 0.00 |
| VAREX IMAGIN (Varex Imaging Corp) | Long | Equity-common | US | $2M | 139K | 0.01 |
| VAXART INC | Long | Equity-common | US | $431K | 529K | 0.00 |
| VAXCYTE INC | Long | Equity-common | US | $21M | 305K | 0.11 |
| VEEVA SYSTEMS-A (Veeva Systems Inc) | Long | Equity-common | US | $90M | 518K | 0.44 |
| VENTYX BIOSCIENC (Ventyx Biosciences Inc) | Long | Equity-common | US | $718K | 150K | 0.00 |
| VERACYTE INC | Long | Equity-common | US | $5M | 248K | 0.03 |
| VERICEL CORP | Long | Equity-common | US | $7M | 153K | 0.04 |
| VERTEX PHARM (Vertex Pharmaceuticals Inc) | Long | Equity-common | US | $398M | 873K | 1.95 |
| VERVE THERAPEUTI (Verve Therapeutics Inc) | Long | Equity-common | US | $922K | 178K | 0.00 |
| VIATRIS INC | Long | Equity-common | US | $43M | 4M | 0.21 |
| VIKING THERAPEUT (Viking Therapeutics Inc) | Long | Equity-common | US | $18M | 288K | 0.09 |
| VIR BIOTECHNOLOG (Vir Biotechnology Inc) | Long | Equity-common | US | $3M | 321K | 0.02 |
| VIRIDIAN THERAPE (Viridian Therapeutics Inc) | Long | Equity-common | US | $2M | 141K | 0.01 |
| WATERS CORP | Long | Equity-common | US | $62M | 200K | 0.30 |
| WEST PHARMACEUT (West Pharmaceutical Services Inc) | Long | Equity-common | US | $83M | 251K | 0.41 |
| XENCOR INC | Long | Equity-common | US | $4M | 187K | 0.02 |
| XENON PHARMACEUT (Xenon Pharmaceuticals Inc) | Long | Equity-common | US | $8M | 213K | 0.04 |
| Y-MABS THERAPEUT (Y-mAbs Therapeutics Inc) | Long | Equity-common | US | $1M | 118K | 0.01 |
| ZENTALIS PHARMAC (Zentalis Pharmaceuticals Inc) | Long | Equity-common | US | $2M | 168K | 0.01 |
| ZIMMER BIOMET HO (Zimmer Biomet Holdings Inc) | Long | Equity-common | US | $82M | 708K | 0.40 |
| ZIMVIE INC | Long | Equity-common | US | $1M | 89K | 0.01 |
| ZOETIS INC | Long | Equity-common | US | $264M | 2M | 1.29 |
Address
VANGUARD WORLD FUND
100 VANGUARD BOULEVARD
MALVERN
Pennsylvania
19355
United States of America
Websites
Directors
Tara Bunch
Emerson U. Fullwood
Grant Reid
David Thomas
Peter F. Volanakis
F. Joseph Loughrey
Mortimer J. Buckley
Deanna Mulligan
Andre F. Perold
Sarah Bloom Raskin
Mark Loughridge
Scott C. Malpass
Transfer Agents
THE VANGUARD GROUP, INC.
Pricing Services
Refinitiv US LLC
Markit Group Limited
ITG Analytics Inc
ICE Data Pricing and Reference Data LLC
Markit North America INC
JPMorgan Chase Bank
Bloomberg Finance LP
Custodians
GCD Denmark
Euroclear
Standard Chartered Bank Korea Limited
JPMorgan Chase Bank NA
JPMorgan Chase Bank NA
HSBC Bank Middle East Limited
Bank Handlowy w Warszawie SA
JPMorgan Chase Bank NA
Mizuho Bank Ltd
UniCredit Bank Austria AG
Citibank NA
UBS Switzerland AG
HSBC Bank Malaysia Berhad
J.P. MORGAN SE - LUXEMBOURG BRANCH
PT Bank HSBC Indonesia
BNP Paribas Securities Services SCA
JPMorgan Chase Bank NA
Skandinaviska Enskilda Banken AB (publ)
Banco Santander Chile
JP Morgan SA DTVM
Standard Chartered Bank Pakistan Limited
Cititrust Colombia SA
Euroclear
JPMorgan Chase Bank NA
BNP Paribas S.A. - Athens Branch
Banco Nacional de Mexico SA
Royal Bank of Canada
JP Morgan Saudi Arabia Company
JP Morgan Bank International Limited Liability Company
Standard Chartered Bank Thai Public Company Limited
J.P. MORGAN SE - LUXEMBOURG BRANCH
HSBC Bank Middle East Limited
J.P. MORGAN SE - LUXEMBOURG BRANCH
Skandinaviska Enskilda Banken AB (publ)
JPMorgan Chase Bank NA
BNP Paribas Securities Services SCA
Citibank AS
Islandsbanki hf
JPMorgan Chase Bank NA
DBS Bank Ltd
Citibank Europe plc
Deutsche Bank AG
HSBC Bank China Company Limited
Deutsche Bank AG
Skandinaviska Enskilda Banken AB (publ)
HSBC Bank Middle East Limited
Citibank del Peru SA
UniCredit Bank Czech Republic and Slovakia as
CACEIS Bank Spain SAU
Bank Leumi leIsrael BM
FirstRand Bank Limited
The Hongkong and Shanghai Banking Corporation Limited
Shareholder Servicing Agents
THE VANGUARD GROUP, INC.
Admins
THE VANGUARD GROUP, INC.
JPMorgan Chase Bank, N.A.
Brokers
BNP Paribas Securities Services SCA
Morgan Stanley & Co. LLC
Credit Suisse AG
Merrill Lynch International
J.P. Morgan Securities (Asia Pacific) Limited
J.P. Morgan Securities PLC
Instinet Pacific Limited
Goldman Sachs International
J.P. Morgan India Private Limited
J.P. Morgan Securities LLC